drug
NGN-401
Phase 3updated 6mo agoby $NGNE Neurogene Inc.
Phase 3community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying NGN-401
News(1)
- Neurogene, Taysha near finish line in ‘two-horse race’ for first Rett syndrome gene therapyAs both Taysha Gene Therapies and Neurogene warm up for an important year of readouts, the Rett syndrome community is hopeful of seeing a therapy that can truly change the disease's path.biospace · 24d ago
Data sources
last refreshed 7h ago
Found something off?
comments(0)
5-min edit window · permanent after that